This is a Validated Antibody Database (VAD) review about human TNFRSF14, based on 8 published articles (read how Labome selects the articles), using TNFRSF14 antibody in all methods. It is aimed to help Labome visitors find the most suited TNFRSF14 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TNFRSF14 synonym: ATAR; CD270; HVEA; HVEM; LIGHTR; TR2

BioLegend
mouse monoclonal (122)
  • flow cytometry; mouse; 1:100; fig 1k
BioLegend TNFRSF14 antibody (Biolegend, 318805) was used in flow cytometry on mouse samples at 1:100 (fig 1k). Nat Commun (2021) ncbi
mouse monoclonal (122)
  • flow cytometry; human; loading ...; fig 3b
BioLegend TNFRSF14 antibody (Biolegend, 318809) was used in flow cytometry on human samples (fig 3b). Cell Rep (2019) ncbi
mouse monoclonal (122)
  • flow cytometry; human; loading ...; fig s5a
BioLegend TNFRSF14 antibody (Biolegend, 122) was used in flow cytometry on human samples (fig s5a). JCI Insight (2018) ncbi
mouse monoclonal (122)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BioLegend TNFRSF14 antibody (BioLegen d, 318806) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (CW10)
  • flow cytometry; human; fig 3b
Santa Cruz Biotechnology TNFRSF14 antibody (Santa Cruz, sc-21718) was used in flow cytometry on human samples (fig 3b). Gene Ther (2016) ncbi
mouse monoclonal (CW10)
  • flow cytometry; human
Santa Cruz Biotechnology TNFRSF14 antibody (Santa Cruz Biotechnology, sc-21718) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (D-5)
  • immunocytochemistry; mouse; 1:200
Santa Cruz Biotechnology TNFRSF14 antibody (Santa Cruz Biotechnology, sc-365971) was used in immunocytochemistry on mouse samples at 1:200. Glia (2014) ncbi
BD Biosciences
mouse monoclonal (94801)
  • flow cytometry; human; loading ...; fig 6a
In order to define the contribution of CD103+ tumor-infiltrating lymphocytes to high-grade serous epithelial ovarian cancer, BD Biosciences TNFRSF14 antibody (BD Biosciences, 94801) was used in flow cytometry on human samples (fig 6a). Oncotarget (2016) ncbi
Articles Reviewed
  1. Arenas E, Martínez Sabadell A, Rius Ruiz I, Román Alonso M, Escorihuela M, Luque A, et al. Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation. Nat Commun. 2021;12:1237 pubmed publisher
  2. Celis Gutierrez J, Blattmann P, Zhai Y, Jarmuzynski N, Ruminski K, Gregoire C, et al. Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy. Cell Rep. 2019;27:3315-3330.e7 pubmed publisher
  3. Liu R, Merola J, Manes T, Qin L, Tietjen G, Lopez Giraldez F, et al. Interferon-γ converts human microvascular pericytes into negative regulators of alloimmunity through induction of indoleamine 2,3-dioxygenase 1. JCI Insight. 2018;3: pubmed publisher
  4. Komdeur F, Wouters M, Workel H, Tijans A, Terwindt A, Brunekreeft K, et al. CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy. Oncotarget. 2016;7:75130-75144 pubmed publisher
  5. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  6. Wang P, Swain H, Kunkler A, Chen C, Hutzen B, Arnold M, et al. Neuroblastomas vary widely in their sensitivities to herpes simplex virotherapy unrelated to virus receptors and susceptibility. Gene Ther. 2016;23:135-43 pubmed publisher
  7. Bolyard C, Yoo J, Wang P, Saini U, Rath K, Cripe T, et al. Doxorubicin synergizes with 34.5ENVE to enhance antitumor efficacy against metastatic ovarian cancer. Clin Cancer Res. 2014;20:6479-94 pubmed publisher
  8. Chucair Elliott A, Conrady C, Zheng M, Kroll C, Lane T, Carr D. Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells. Glia. 2014;62:1418-34 pubmed publisher